| Effect | Decrease |
| Trial Design | Double blind |
| Trial Length | 1-6 months |
| Number of Subjects | 630 |
| Gender | Both Genders |
| Age Range | 45-64, 65+ |
| Body Types | Overweight, Average |
Using data from the CAMS trial (large double blind trial) during a secondary analysis, it appeared that usage of cannabis sativa or isolated THC supplements conferring 25mg THC for 15 weeks appears to significantly reduce rates of incontinence in persons with multiple sclerosis, with reported clinical improvements of 18% in placebo being outperformed by 33-38% with marijuana containing groups.
